IRadimed Corporation
IRMD
$96.84
$0.080.08%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 3.88% | 4.61% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 3.88% | 4.61% | |||
| Cost of Revenue | 5.69% | -4.57% | |||
| Gross Profit | 3.38% | 7.49% | |||
| SG&A Expenses | 8.28% | -5.66% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 5.48% | -3.25% | |||
| Operating Income | 0.67% | 24.97% | |||
| Income Before Tax | -0.40% | 23.24% | |||
| Income Tax Expenses | 10.80% | 23.47% | |||
| Earnings from Continuing Operations | -3.42% | 23.18% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -3.42% | 23.18% | |||
| EBIT | 0.67% | 24.97% | |||
| EBITDA | 3.17% | 24.35% | |||
| EPS Basic | -3.46% | 23.16% | |||
| Normalized Basic EPS | -0.42% | 23.20% | |||
| EPS Diluted | -4.44% | 22.05% | |||
| Normalized Diluted EPS | -0.59% | 23.16% | |||
| Average Basic Shares Outstanding | 0.04% | 0.01% | |||
| Average Diluted Shares Outstanding | 0.19% | 0.08% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | 0.04% | -0.19% | |||